ID

27542

Descripción

Study Part: Investigator’s Statement Follow-Up. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Palabras clave

  1. 20/11/17 20/11/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

20 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Investigator’s Statement Follow-Up Ropinirole Parkinson Disease 101468/165

Investigator’s Statement Follow-Up

INVESTIGATOR’S STATEMENT
Descripción

INVESTIGATOR’S STATEMENT

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C1710187
Patient Number
Descripción

Patient Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Descripción

Centre Number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Check all Adverse Event forms are up to date and complete
Descripción

Adverse Event

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0877248
Check that the Concomitant Medication form is up to date
Descripción

Concomitant Medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347852
Check that all appropriate pages are signed (thus indicating completion) and dated
Descripción

consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1511481
Check that laboratory results are included
Descripción

laboratory results

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1254595
I certify that the observations and findings are recorded correctly and completely in this CRF.
Descripción

complete

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0205197
Investigator:
Descripción

Investigator

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Date:
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008

Similar models

Investigator’s Statement Follow-Up

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
INVESTIGATOR’S STATEMENT
C0008961 (UMLS CUI-1)
C1710187 (UMLS CUI-2)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Adverse Event
Item
Check all Adverse Event forms are up to date and complete
boolean
C0877248 (UMLS CUI [1])
Concomitant Medication
Item
Check that the Concomitant Medication form is up to date
boolean
C2347852 (UMLS CUI [1])
consent
Item
Check that all appropriate pages are signed (thus indicating completion) and dated
boolean
C1511481 (UMLS CUI [1])
laboratory results
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1])
complete
Item
I certify that the observations and findings are recorded correctly and completely in this CRF.
boolean
C0205197 (UMLS CUI [1])
Investigator
Item
Investigator:
text
C2826892 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial